To control Covid-19 in a more effective way, leading face mask manufacturers have adopted technologies like Virus Protection Technology (VPT) approved by regulatory authorities globally to ensure maximum breathability while ensuring protection through anti-viral and anti-bacterial coating.
Alarmed with the new strain of virus post Covid-19 outbreak, Union health ministry is also in the process of evolving harmonized standard for community face coverings and is encouraging manufacturers to develop uniquely designed breath-easy mask equipped with superior technologies like VPT to ensure maximum breathability while keeping the consumer and patient protected.
The proprietary VPT technology which has been developed by leading mask manufacturer Guardwiser in India is a non-alcoholic, non-heavy metal based – food grade product. It has naturally derived ingredients sourced from coconut oil. VPT technology is a single solution for multiple problems such as bacteria, viruses, fungi and mold. The mask is stabilized in food grade aqueous solution whereas other mask coating is metal based. The technology is non-leaching, locking and bonding technology. It kills microbes by a mechanical process and not by a chemical method.
ADVANTAGE of VPT technology
- Proven to have 99.9% anti-bacterial & anti-odour efficacy even after 100 washes
- Anti-viral efficacy even after 50 washes
- N99 filter between the two fabric layers filters more than 99% of airborne particulate matter greater than 2.5 microns
- The non-leaching, locking and bonding technology and sticks to garment for up to 100 washes
- Uniqueness lies in green technology as it decomposes like oxygen, nitrogen and sand
- Does not penetrate the skin nor accumulates in the environment and does not contain carcinogenic compounds
Whereas other mask coating is metal based and erodes after a few washes. Chemical methods used in such mask to kill microbes pollute riverbeds, soil and environment. It also bio accumulates in body and environment and contains carcinogenic compounds.
N99 Breath easy mask is equipped with the revolutionary breakthrough VPT. Its ingredients are approved by USEPA, European BPR, New Zealand primary industry for the use of food contact surfaces and Therapeutic Goods Administration (TGA), Ministry of Health, Australia for the claim against corona virus.
AstraZeneca and MSD’s Lynparza (olaparib) has shown efficacy in preventing cancer recurrence in patients with germline BRCA-mutated (gBRCAm) high-risk human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.
Ammonia saved the world once; it might do it again. A century ago, the world faced a looming food crisis. A booming population was pushing farmers to grow crops faster than nitrogen-fixing bacteria in the soil could keep up, and the South American deposits of guano and natural nitrates they applied as fertilizer were dwindling.
Lipids are an unsung component in the two mRNA-based shots, the only vaccines to be approved so far in the US. Naked mRNA quickly degrades in the body and can trigger an unwanted immune reaction. To get the genetic material to its target cells, vaccine developers combine it with a mixture of several sophisticated lipids to form lipid nanoparticles, or LNPs. mRNA vaccine producers use a package of 4 lipids to formulate their LNPs
An unprecedented push to manufacture billions of doses this year alone has led to supply bottlenecks, putting firms such as Pfizer and AstraZeneca Plc in the firing line of angry government customers. Now the industry is taking heat for closely guarding its intellectual property.
Australian company, Vaxine Pty Ltd, has developed a protein based COVID-19 vaccine that completely blocks virus transmission to non-immune individuals.
If one positive could be drawn out of the devastating global COVID 19 crisis, it is the fact that this calamitous pandemic has made people more conscious about the need for healthier lifestyles, nutrition as well as their environmental footprint.
India’s devastating Covid-19 crisis is threatening operations at some of its biggest ports, raising concerns. The action could trigger shipping delays that reverberate through global supply chains.
A team of driven, concerned, caring citizens who decided to make a difference!
Over the last year, several drugs have either been developed or tested to treat coronavirus. Now there’s another new antiviral drug that’s showing some promise by demonstrating ability to stop SARS-CoV-2 transmission within 24 hour!